The new plant is touted as the only co-located, commercial-scale, multi-radioisotope production and radiopharmaceutical manufacturing facility in the U.S.
Hooman Hakami had acted as interim CEO of a Twin Cities medtech. Now Hakami, who once led a $3 billion business at GE HealthCare, becomes chair of the company's board.